Leading With Lived Experience: Why Rare Disease Leadership Starts With Patients

Rare disease leadership doesn’t start in the boardroom - it starts with patients.

Sponsored by Health Union
17th February 2026

The path to a rare disease diagnosis and treatment is often one marked by isolation, uncertainty, and constant self-advocacy. For marketers, researchers, and patient advocates, truly leading in the rare disease space requires a foundational understanding of this unique lived experience and a commitment to placing the patient and caregiver at the very center of every strategy.  

This is the core of Health Union’s leadership in the rare disease community – a philosophy championed by Health Union President and COO, Lauren Lawhon, who emphasizes that true innovation begins with listening to the patient voice. 

The Unique Journey of the Rare Disease Patient 

Individuals and families managing rare conditions navigate a reality distinct from those with more well-known conditions. Insights from Health Union’s Rare Disease In America study highlight the significant burden and the ways in which these patients and caregivers are forced to become “experts” in their own care. 

Behaviors and Challenges: 

  • The Long Road to Diagnosis: Often, the journey to a diagnosis can be long and taxing, with 16% of rare disease patients and caregivers saying it took more than 5 years to receive a diagnosis after first seeking medical care. During this time, 41% report that their concerns were initially dismissed by healthcare professionals. 
  • Active, Empowered Learners: Patients and caregivers are highly engaged in seeking knowledge, with 61% actively seeking information about treatment options....
Most Popular Content